(Q45859169)

17 December 2017

title

Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia (English)

1 reference

17 December 2017

0 references

2

1 reference

17 December 2017

Dougald M. Monroe

series ordinal

4

1 reference

17 December 2017

Geoffrey A Allen

object named as

Geoffrey A Allen

series ordinal

1

0 references

author name string

Harold R Roberts

series ordinal

3

1 reference

17 December 2017

language of work or name

English

0 references

publication date

20 June 2006

1 reference

17 December 2017

British Journal of Haematology

published in

1 reference

17 December 2017

volume

134

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

314-319

1 reference

17 December 2017

Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06178.X

A rapid method to isolate platelets from human blood by density gradient centrifugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06178.X

FEIBA safety profile in multiple modes of clinical and home-therapy application

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06178.X

Platelet activity of high-dose factor VIIa is independent of tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06178.X

A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06178.X

Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06178.X

A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa a

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06178.X

Monitoring the bioavailability of FEIBA with a thrombin generation assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06178.X

10.1111/J.1365-2141.2006.06178.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017